Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
135.50    -1.50 (-1.09%)
Bid:
135.50
Ask:
141.50
Spread: 6.00 (4.428%)
Market Cap: £106.33m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Director/PDMR Shareholding

23 Apr 2020 14:35

RNS Number : 6939K
Xaar PLC
23 April 2020
 

Xaar plc (the "Company")

Director/PDMR Shareholding

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES OR CONNECTED PERSONS

This notification is made in accordance with the requirements of the Market Abuse Regulation

John Mills

The Company was notified on 23 April 2020 John Mills, Chief Executive Officer, has today acquired 125,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 39.3509 pence per Ordinary Share. Following this transaction, John Mills's beneficial interest in the Company is 125,000 Ordinary Shares representing 0.16% of the current issued share capital of the Company.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

John Mills

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Xaar Plc

b)

 

LEI

 

 

213800MXEC3KAOBBPO57

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

GB0001570810

b)

 

Nature of the transaction

 

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

39.3509p

125,000

d)

 

Aggregated information

- Aggregated volume

125,000

- Price

39.3509p

e)

 

Date of the transaction

 

 

23 April 2020

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

Ian Tichias

The Company was notified on 23 April 2020 Ian Tichias, Chief Finance Officer, has today acquired 50,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 39.3509 pence per Ordinary Share. Following this transaction, Ian Tichias beneficial interest in the Company is 50,000 Ordinary Shares representing 0.064% of the current issued share capital of the Company.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Ian Tichias

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Finance Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Xaar Plc

b)

 

LEI

 

 

213800MXEC3KAOBBPO57

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

GB0001570810

b)

 

Nature of the transaction

 

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

39.3509p

50,000

d)

 

Aggregated information

- Aggregated volume

50,000

- Price

39.3509p

e)

 

Date of the transaction

 

 

23 April 2020

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

Andrew Herbert

The Company was notified on 23 April 2020 Andrew Herbert, Chairman, has today acquired 100,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 39.3509 pence per Ordinary Share. Following this transaction, Andrew Herbert's beneficial interest in the Company is 100,000 Ordinary Shares representing 0.13% of the current issued share capital of the Company.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Andrew Herbert

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chairman

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Xaar Plc

b)

 

LEI

 

 

213800MXEC3KAOBBPO57

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

GB0001570810

b)

 

Nature of the transaction

 

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

39.3509p

100,000

d)

 

Aggregated information

- Aggregated volume

100,000

- Price

39.3509p

e)

 

Date of the transaction

 

 

23 April 2020

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

Enquiries:

Xaar plc

+44 (0) 1223 423 663

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFVVSVIVFII
Date   Source Headline
21st Sep 20239:57 amRNSHolding(s) in Company
19th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20232:11 pmRNSHolding(s) in Company
11th Sep 202312:14 pmRNSHolding(s) in Company
11th Sep 202312:07 pmRNSHolding(s) in Company
11th Sep 202312:03 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
7th Sep 20239:00 amRNSNotice of 2023 Half Year Results
1st Sep 20239:30 amRNSTotal Voting Rights
25th Aug 202312:13 pmRNSHolding(s) in Company
23rd Aug 202310:24 amRNSHolding(s) in Company
18th Aug 202310:30 amRNSChange of Auditor
17th Aug 202312:55 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSTrading Update
1st Aug 20232:00 pmRNSTotal Voting Rights
28th Jul 20234:30 pmRNSHolding(s) in Company
5th Jul 20239:00 amRNSXaar plc - Commercial partnership with Quantica
4th Jul 20233:00 pmRNSBlock listing Interim Review
3rd Jul 20232:53 pmRNSTotal Voting Rights
1st Jun 202310:37 amRNSTotal Voting Rights
31st May 202311:30 amRNSResult of AGM
31st May 20239:00 amRNSBoard Changes
11th May 20235:41 pmRNSHolding(s) in Company
10th May 20233:10 pmRNSDirector/PDMR Shareholding
2nd May 202312:39 pmRNSTotal Voting Rights
24th Apr 20231:05 pmRNSAnnual Financial Report
3rd Apr 20234:51 pmRNSTotal Voting Rights
28th Mar 20237:00 amRNSFinal Results
20th Mar 20232:00 pmRNSNotification of the 2022 Full Year Results Date
1st Mar 20233:19 pmRNSTotal Voting Rights
20th Feb 202312:35 pmRNSHolding(s) in Company
1st Feb 202312:30 pmRNSTotal Voting Rights
30th Jan 202312:30 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSTrading Update
5th Dec 202210:21 amRNSDirector/PDMR Shareholding
1st Dec 202210:19 amRNSTotal Voting Rights
21st Nov 20224:41 pmRNSSecond Price Monitoring Extn
21st Nov 20224:35 pmRNSPrice Monitoring Extension
3rd Nov 20221:38 pmRNSGrant of Sharesave Options
1st Nov 202210:41 amRNSTotal Voting Rights
13th Oct 20222:20 pmRNSHolding(s) in Company
3rd Oct 20224:07 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNS2022 INTERIM RESULTS
1st Sep 20225:32 pmRNSTotal Voting Rights
30th Aug 202210:26 amRNSNotice of 2022 Half Year Results
1st Aug 20224:33 pmRNSTotal Voting Rights
1st Aug 202211:25 amRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
1st Jul 20221:14 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.